In @entity1 affected by @entity5 , nutritional status is important to sustain aggressive chemotherapy and to support normal growth during and after therapy. The aim of this study was to investigate the prevalence of @entity17304 in a sample of pediatric oncology day-hospital @entity1 . We measured weight and height in @entity1 affected by solid @entity5 on or off therapy at short-term follow-up (1-24 mo). The study was performed at a pediatric oncology day-hospital over a period of 20 consecutive days. A suitable computer package was used to estimate relative body weight (%RBW) and body mass index (BMI) for each @entity1 . Thereafter, the same sample was divided into four weight classes (underweight, normal weight, overweight, and @entity28 ) according to %RBW and BMI. Moreover, @entity1 were divided into two groups: on and off therapy. In the off-therapy group, no @entity1 was underweight; in the on-therapy group, 26.3% and 15.8% of @entity1 were underweight (not significant) according to %RBW and BMI, respectively. The prevalence of overweight (overweight ++ @entity28 ) according to %RBW was 36.9% in the on-therapy group and 52.9% in the off-therapy group (P < 0.05); whereas the prevalence of overweight according to BMI was 21% in the on-therapy group and 35.3% in the off-therapy group (P = 0.05). These preliminary data suggest that, in pediatric oncology, nutritional assessment is required to provide nutritional strategies in on-therapy @entity1 whose underweight status prevalence is impressive or in off-therapy @entity1 in whom the causes of overweight should be explored.

Nutritional status in childhood XXXX .

@entity1 :: ('9606', 'Species') :: ['children', 'patients', 'patient'] @entity17304 :: ('MESH:D009748', 'Disease') :: ['nutritional status disorders'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'tumors'] @entity28 :: ('MESH:D009765', 'Disease') :: ['obese']
@entity5 :: (MESH:D009369,Disease) :: ['malignancies']
